Glauconix Biosciences Announces Appointment of Mrs. Kimberly Southern as Chief Operating Officer

Tuesday, August 6, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Appointment reflects Glauconix Biosciences' commitment to business and organizational excellence as they continue on their trajectory to become the leading developer of ex vivo-like 3D human tissue models for accelerating therapeutic innovation and drug discovery



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store